Article

Rajeev, SP, Roberts, CA, Brown, E, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Perry, J, Howarth, E, Jackson, R, Wiemken, A, Schwab, R, Cuthbertson, DJ and Wilding, JPH (2023) No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes, Obesity and Metabolism. ISSN 1462-8902